A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19
News Release February 06, 2025 Best Joint Health Supplements, According to ConsumerLab Tests White Plains, NY, February 6, 2025 Recent ConsumerLab tests of popular joint health supplements found several contained far less of one or more key ingredients than claimed
If Ozempic is working for you as a weight loss medication, it will usually be prescribed on a long-term basis
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes In patients with preexisting cardiovascular disease and overweight or obesity but without diabetes, weekly subcutaneous semaglutide at a dose of 2.4 mg was superior to placebo in reducing the incidence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke at a mean follow-up of 39.8 months #AHA2023 nejm.org/doi/full/10.10 Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes In patients with preexisting cardiovascular disease and overweight or obesity but without diabetes, weekly subcutaneous semaglutide at a dose of 2.4 mg was superior to placebo in reducing the incidence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke at a mean follow-up of 39.8 months #AHA2023 nejm.org/doi/full/10.10 Join the conversation
Methylated B12 is also easier on the kidneys, per Attia
